Shortly after joint remobilization,
inflammation is induced in the joint and aggravates joint
contracture via subsequent
fibrosis. However, the mechanisms involved in remobilization-induced
inflammation are not yet fully understood. We hypothesized that joint immobilization followed by remobilization induces
hypoxia/reoxygenation, initiating inflammatory reactions through
nitric oxide (NO) production via
NO synthase 2 (NOS2). This study aimed to investigate whether: 1) administration of the NOS inhibitor L-
NG-nitroarginine methyl ester (
l-NAME) can attenuate remobilization-induced joint
inflammation; and 2)
hypoxia/reoxygenation is induced by joint immobilization and followed by remobilization. Unilateral knee joints of rats were immobilized using
external fixators for three weeks. After removal of the fixation device, knees were allowed to move freely for one day (remobilization) with or without
l-NAME administration. Without
l-NAME administration, inflammatory reactions including joint swelling and inflammatory cell infiltration,
edema, and upregulation of inflammatory mediator genes in the joint capsule were detected following upregulation of the NOS2 gene after remobilization. These remobilization-induced inflammatory reactions were partially attenuated by administration of
l-NAME. Therefore, NOS2/NO elevation has potential as a novel treatment for remobilization-induced joint
inflammation. Gene expression of the
hypoxia marker
hypoxia inducible factor-1α was upregulated after one day of remobilization, rather than after immobilization. These results suggest that upregulation of NOS2 by remobilization might be not due to
hypoxia/reoxygenation.